(Press-News.org) A new tool called DeepBind uses deep learning to analyze how proteins bind to DNA and RNA, allowing it to detect mutations that could disrupt cellular processes and cause disease.
CIFAR Senior Fellow Brendan Frey (University of Toronto), supervising lead authors Babak Alipanahi and Andrew Delong, developed the method using deep learning -- a machine learning technique pioneered by CIFAR fellows in the Neural Computation & Adaptive Perception program and now used by companies such as Google and Facebook.
Hundreds of thousands of proteins in human cells attach themselves to DNA and RNA and regulate gene expression. "They are master controllers of the cell," Alipanahi says. But many of these proteins are picky about which sequences they will bind to.
DeepBind can analyze noisy experimental data to determine the DNA and RNA sequences to which a set of proteins will bind. Then, it can look at a new sequence and compute a score saying how likely it is that any of these proteins would bind to it. Given a sequence with a mutation, the tool can analyze whether binding changes. Mutations that add or delete protein binding sites can alter gene expression patterns and lead to disease.
Frey, a senior fellow in both the program in Genetic Networks and the program in Neural Computation & Adaptive Perception, says, "DeepBind is one example of a series of technologies that we have developed by combining our expertise in deep learning and genome biology. I believe that these technologies will revolutionize health care and precision medicine. They are game changers."
Frey's group has been developing disruptive machine learning techniques to understand the genome for over a decade. Just last year, technology leaders from companies like Facebook, Google and Deep Mind agreed that the next "big thing" for deep learning is its application in health care and genomic medicine. Based on their successes over the past decade, Frey's group couldn't agree more.
DeepBind's first analyses of human genetic data, described in Nature Biotechnology, has already provided new information about disruptions to protein binding in mutations tied to cancers, haemophilia and familial hypercholesterolemia -- a hereditary condition associated with very high levels of cholesterol. The system also revealed that a genetic mutation leading to abnormal development of the brain's cerebral cortex may be more complex than previously thought. Specifically, a mutation that is known to delete one binding site was found to actually delete two binding sites at the same time.
DeepBind follows the breakthrough development of the "human splicing code" by Frey's group in collaboration with CIFAR senior fellows Stephen Scherer (The Hospital for Sick Children and the University of Toronto) and Timothy Hughes (University of Toronto). Their system identified new genes that could be implicated in autism spectrum disorders, hereditary non-polyposis colon cancer and spinal muscular atrophy by identifying errors in gene splicing. Since many proteins regulate splicing, the researchers intend to use their insights from DeepBind to improve the human splicing code. The new tool substantially expands the types of mutations they can analyze to promoters and enhancers.
Frey says that the concepts behind DeepBind were highly influenced by CIFAR collaborators who are at the forefront of developing deep learning technologies. "CIFAR played a crucial role in establishing the research network that led to our breakthroughs in deep learning and genomic medicine," Frey says.
INFORMATION:
Reference: Babak Alipanahi, Andrew Delong, Matthew T Weirauch, Brendan J Frey, "Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning," Nature Biotechnology, Advanced Online Publication July 27, 2015, doi:10.1038/nbt.3300
About CIFAR
CIFAR creates knowledge that is transforming our world. Established in 1982, the Institute brings together interdisciplinary groups of extraordinary researchers from around the globe to address questions and challenges of importance to the world. Our networks help support the growth of research leaders and are catalysts for change in business, government and society. CIFAR is generously supported by the governments of Canada, British Columbia, Alberta, Ontario and Quebec, Canadian and international partners, as well as individuals, foundations and corporations.
Contact:
Laura Matthews
Director of Marketing and Communications
lmatthews@cifar.ca
416-971-4152
About 10 percent of serious and unexpected adverse events are not reported by drug manufacturers to the U.S. Food and Drug Administration under the 15-day timeframe set out in federal regulations, according to an article published online by JAMA Internal Medicine.
Health care professionals and consumers can voluntarily report adverse drug events directly to the FDA or the drug manufacturer. Adverse events that are serious (including death, life-threatening, hospitalization, disability and birth defects) and unexpected (any adverse experience not listed in the current ...
An imaging study suggests insulin resistance, a prevalent and increasingly common condition, was associated with lower brain glucose metabolism in a group of late middle-age adults at risk for Alzheimer disease, according to an article published online by JAMA Neurology.
Insulin resistance is broadly defined as reduced tissue responsiveness to the action of insulin. According to the American Diabetes Association, 29.1 million individuals in the United States have diabetes and more than half of adults older than 64 have prediabetes. Type 2 diabetes is associated with an ...
Admission rates are increasing for newborns of all weights at neonatal intensive care units (NICUs) in the United States, raising questions about possible overuse of this highly specialized and expensive care in some newborns, according to an article published online by JAMA Pediatrics.
The neonatal mortality rate has fallen more than four-fold (from 18.73 per 1,000 live births to 4.04 per 1,000 live births in 2012) since the first NICU opened in the United States 55 years ago to provide highly specialized care to premature and sick infants.
Few studies have looked ...
No earlier than last year, did the first, and up until recently only, endemic to Upper Guinea family of torrent tooth-frog come to light. Now, Dr. Michael F. Barej from the Museum für Naturkunde, Berlin, and his colleagues verify the existence of as many as four new highly endangered species. In their study the researchers provide crucial insights for the conservation of the biodiversity hotspot. Their research on the suggested existence of a complex of cryptic (structurally identical) species is published in the open-access journal Zoosystematics and Evolution.
Suffice ...
Quantum technology based on light (photons) has great potential for radically new information technology based on photonic circuits. Up to now, the photons in quantum photonic circuits have behaved in the same way whether they moved forward or backward in a photonic channel. This has limited the ability to control the photons and thus build complex circuits for photonic quantum computers. Now researchers from the Niels Bohr Institute have discovered a new type of photonic channels, where back and forth are not equal distances! Such a system has been a missing component ...
New Haven, Conn. -- A multidisciplinary team at Yale, led by Yale Cancer Center members, has defined a subgroup of genetic mutations that are present in a significant number of melanoma skin cancer cases. Their findings shed light on an important mutation in this deadly disease, and may lead to more targeted anti-cancer therapies.
The study was published July 27 in Nature Genetics.
The role of mutations in numerous genes and genomic changes in the development of melanoma -- a skin cancer with over 70,000 new cases reported in the United States each year -- is well established ...
Acute lymphoblastic leukemia (ALL) frequently develops between the age of two and three. This leukemia has various forms, which differ through certain changes in the genetic material of the leukemia cells. A team of scientists involved in a joint international project headed by Jean-Pierre Bourquin, a pediatric oncologist from the University Children's Hospital Zurich, and Martin Stanulla, a professor at Hannover Medical School, has now succeeded in decoding the genome and transcriptome of an as yet incurable sub-type of acute lymphoblastic leukemia. These results were ...
In February 1880 in his laboratory in Washington the American inventor Alexander Graham Bell developed a device which he himself called his greatest achievement, greater even than the telephone: the "photophone". Bell's idea to transmit spoken words over large distances using light was the forerunner of a technology without which the modern internet would be unthinkable. Today, huge amounts of data are sent incredibly fast through fibre-optic cables as light pulses. For that purpose they first have to be converted from electrical signals, which are used by computers and ...
Bethesda, MD (July 27, 2015) -- Weight loss through both lifestyle modification and bariatric surgery can significantly reduce features of nonalcoholic steatohepatitis (NASH), a disease characterized by fat in the liver, according to two new studies published in Gastroenterology, the official journal of the American Gastroenterological Association.
"While the underlying cause of NASH is unclear, we most commonly see this condition in patients who are middle-aged and overweight or obese," said Giulio Marchesini, MD, from University of Bologna, Italy, and lead author of ...
As the International Olympic Committee prepares to choose between Beijing (China) and Almaty (Kazakhstan) as the host of the 2022 Winter Olympics, a new report shows that the cost of last year's Games in Sochi, Russia, has been underestimated by billions of dollars.
Ahead of the decision on 31 July, a study by Dr Martin Müller of the University of Birmingham finds that:
The Sochi Games cost $16bn in sports-related expenditure alone - more than twice the official figure of $7bn
Total costs, including capital costs, amount to $55bn
Sochi is the most expensive ...
